Alembic Pharmaceuticals informs about annual secretarial compliance report

12 May 2022 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, Alembic Pharmaceuticals has informed that it enclosed the Annual Secretarial Compliance Report issued by Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2022.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

837.80 -14.50 (-1.70%)
29-Dec-2025 14:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.00
Dr. Reddys Lab 1266.30
Cipla 1496.65
Zydus Lifesciences 906.20
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×